Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,682 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06269809 | Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled Trial(TACROM) | recruiting | N/A | 82 | Universitaire Ziekenhuizen KU LeuvenOTHER | 3 | Mar 14, 2025 | clinicaltrials |
| NCT06861621 | STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers(STRATEGIC) | recruiting | — | 1,000 | University Hospital, RouenOTHER |
| 1 |
| Mar 14, 2025 |
| clinicaltrials |
| NCT06866782 | European Registry of Next Generation Imaging in Advanced Prostate Cancer(RING) | recruiting | — | 600 | Fundacio PuigvertOTHER | 8 | Mar 11, 2025 | clinicaltrials |
| NCT06861023 | Review of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for Melanoma | recruiting | — | 10 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Mar 6, 2025 | clinicaltrials |
| NCT03257969 | Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients with Risk Factors(DROP-SFPO) | recruiting | N/A | 248 | Hospices Civils de LyonOTHER | 1 | Mar 5, 2025 | clinicaltrials |
| NCT06611891 | Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer(DOTABREAST) | recruiting | Phase 3 | 25 | University Hospital, GrenobleOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06045819 | Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX) | recruiting | — | 100 | University Hospital, CaenOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06541184 | Ziconotide for Non-cancer Pain by Intrathecal Administration | recruiting | — | 85 | ESTEVE Pharmaceuticals SASINDUSTRY | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06605417 | Understanding the Transition from Normal Melanocytes to Nevus to Melanoma(NevustoMel) | recruiting | — | 100 | Fundacion Clinic per a la Recerca BiomédicaOTHER | 2 | Feb 27, 2025 | clinicaltrials |
| NCT06846905 | Cost-utility Analysis of Ambulatory Dose Escalation of Bispecific Antibodies in Multiple Myeloma.(AmbuSpé) | recruiting | — | 40 | University Hospital, ToulouseOTHER | 1 | Feb 26, 2025 | clinicaltrials |
| NCT06845982 | Anatomopathological Evaluation of a New Ultrasound-guided Transuterine Vaginal Biopsy Technique in Uterine Fibromatous Disease(EFIBIA) | recruiting | N/A | 250 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT03548428 | Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)(Stereosarc) | recruiting | Phase 2 | 103 | Centre Antoine LacassagneOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT06550687 | Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.(INFOGENE) | recruiting | N/A | 80 | Centre Georges Francois LeclercOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06762405 | PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients(PREDIR-NEOREC) | recruiting | Phase 3 | 68 | Centre Hospitalier Universitaire DijonOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT05783908 | Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions(RespEcran) | recruiting | N/A | 100 | Centre Georges Francois LeclercOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06373211 | Early Immunotherapy with Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients with Anti-Hu-associated Paraneoplastic Sensory Neuronopathy(NESPA) | recruiting | Phase 2 | 21 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06827353 | Niraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination Deficiency(OVNI-B) | recruiting | — | 300 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT04006951 | Development of a Clinical and Biological Database in Rectum Cancer(BCBRectum) | recruiting | N/A | 300 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT05257135 | A Clinico-biological Database in Cachexia in Patients With Colon Cancer(BCBCachexie) | recruiting | N/A | 150 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06809660 | Effects of Endocrine Disruptors on the Gut Microbiota and Assessment of Their Impact on Colorectal Cancer Development (PERMICA)(PERMICA) | recruiting | N/A | 200 | Poitiers University HospitalOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT03410394 | Registry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)(eurocrine) | recruiting | — | 3,000 | Central Hospital, Nancy, FranceOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT03449264 | Development of Clinical and Biological Database(BCBInstitut) | recruiting | N/A | 4,000 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT03976960 | Clinical and Biological Database in Colon Cancer and Colic Tumors(BCBCOLON) | recruiting | N/A | 600 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT03976999 | Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers(BCBOvaire) | recruiting | N/A | 300 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT03978078 | A Clinicobiological Database in Metastatic Digestive Cancers(BCB-CBIO-DIG) | recruiting | N/A | 200 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04103567 | Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers(MICARE) | recruiting | N/A | 220 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04136132 | Prospective Monocentric Clinical-biological Database(BCBPancréas) | recruiting | N/A | 120 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04221464 | Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)(BCB) | recruiting | N/A | 600 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04224064 | Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas(ESPACE) | recruiting | N/A | 158 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04282122 | Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual Radiosensitivity(SAHARA-01) | recruiting | — | 500 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04282356 | Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer(INTENS-IP) | recruiting | Phase 2 | 55 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04356209 | Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life(PRAVACUR-02) | recruiting | Phase 2 | 105 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04458792 | Establishment of a Prospective Clinical-biological Database(BCBSarcome) | recruiting | N/A | 450 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04516720 | Creation of a Clinical Database on Primary Nervous System Tumors(BDD-NO) | recruiting | — | 1,700 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04823923 | Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer(IREKI) | recruiting | N/A | 60 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT05056350 | Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work(VISIBILITE) | recruiting | N/A | 25 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06084195 | Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging(MR-O-MICS) | recruiting | N/A | 120 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06144762 | Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer(PANC-O-MICS) | recruiting | N/A | 150 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT02828202 | Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary(MelBase) | recruiting | — | 6,000 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT03696680 | Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal(STEREO-HBM) | recruiting | Phase 2 | 46 | Centre Francois BaclesseOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT04057924 | Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN(SUIVICIN) | recruiting | — | 200 | University Hospital, BordeauxOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06813573 | Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma(EVOLITION) | recruiting | N/A | 50 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT04886401 | Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLC(PREDICTION) | recruiting | — | 50 | University Hospital, BrestOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06792604 | Host Genome Methylation: a Screening Tool in Anal Cancer Detection(AMethysT) | recruiting | N/A | 770 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06392997 | Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology(GynRNA) | recruiting | — | 2,500 | ZIWIGINDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT05909111 | MR-Only Based Adaptive External Beam Radiation Therapy of Cervical Cancer on Ethos Therapy: Feasibility Study(Ethos Col) | recruiting | N/A | 15 | Recherche cliniqueOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06334965 | Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort(OPERANDI-HCC) | recruiting | N/A | 180 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT05601726 | First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients(ODYSSEY) | recruiting | Phase 1 / Phase 2 | 36 | Advanced BioDesignINDUSTRY | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06364631 | CARE1 Pragmatic Clinical Trial(CARE1) | recruiting | Phase 3 | 1,250 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 4 | Jan 16, 2025 | clinicaltrials |
| NCT06640725 | Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N(TATIANA) | recruiting | Phase 2 | 70 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Jan 15, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials